EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer BeitragOpen Access · CC BY 4.0

A historical review of the biological, semantic and clinical aspects of aspirin resistance

Pierre Fontana, Jean-Luc Reny, Thomas Lecompte

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2026.06.027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Pierre Fontana und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology and Haemostasis, University Hospitals of Geneva, Switzerland; Department of Medicine, Faculty of Medicine, Geneva Platelet Grou…. Hauptthemen laut MEDLINE: Aspirin, Drug Resistance, Platelet Aggregation Inhibitors, Blood Platelets. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspirin is one of the most widely used antithrombotic agents worldwide. Nevertheless, the concept of aspirin resistance has generated sustained controversy for more than 2 decades. Initially introduced in the mid-1990s, the term was inconsistently applied to describe either recurrent ischemic events, despite aspirin therapy, or inadequate platelet inhibition, as measured using various laboratory assays. Reported prevalence estimates consequently varied widely, reflecting profound methodological and semantic heterogeneity rather than a uniform biological concept. This historical review retraced the evolution of knowledge about aspirin pharmacodynamics, from the earliest studies on bleeding time and platelet aggregation to the identification of platelet cyclo-oxygenase-1 as aspirin's molecular target and the recognition of serum thromboxane B2 as a specific biomarker of target inhibition. We examined how reliance on integrative platelet-function tests fostered the concept of apparent resistance, later recognized, in many cases, as pseudo-resistance related to assay choice or pharmacokinetic factors. We then reviewed the clinical, genetic and disease-related determinants of variability in aspirin response, highlighting conditions characterized by accelerated platelet production and turnover, such as essential thrombocythaemia, as a notable exception in which target-guided dosing has influenced practice. Finally, we summarized the outcome studies and guideline statements that uniformly discourage routine testing and aspirin dose escalation. Taken together, the historical evidence supports abandoning the term aspirin resistance in favor of recognizing the variability in platelet reactivity found among patients treated with aspirin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinDrug ResistancePlatelet Aggregation InhibitorsBlood PlateletsHumansPlatelet AggregationHistory, 20th CenturyPlatelet Function TestsCyclooxygenase 1History, 21st CenturyAnimalsBiomarkersThromboxane B2

Stichwörter der Autor:innen

aspirinplatelet aggregationplatelet aggregation inhibitorsthromboxane A2

Substanzen

AspirinPlatelet Aggregation InhibitorsCyclooxygenase 1BiomarkersThromboxane B2

Autor:innen und Institutionen

  • Division of Angiology and Haemostasis, University Hospitals of Geneva, Switzerland; Department of Medicine, Faculty of Medicine, Geneva Platelet Group, University of Geneva, Switzerland. Electronic address: Pierre.Fonta…
  • Department of Medicine, Faculty of Medicine, Geneva Platelet Group, University of Geneva, Switzerland; Division of General Internal Medicine, University Hospitals of Geneva, Switzerland.
  • Vascular Medicine Division, University Hospital of Nancy, University of Lorraine, France; University of Lorraine, France.

Zitieren

APA

Fontana, P., Reny, J. L., & Lecompte, T. (2026). A historical review of the biological, semantic and clinical aspects of aspirin resistance. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2026.06.027

Vancouver

Fontana P, Reny JL, Lecompte T. A historical review of the biological, semantic and clinical aspects of aspirin resistance. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2026.06.027

BibTeX
@article{Fontana2026,
  author = {Fontana, Pierre and Reny, Jean-Luc and Lecompte, Thomas},
  title = {A historical review of the biological, semantic and clinical aspects of aspirin resistance},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2026.06.027}
}
Kostenlos starten →